GLP-1 drugs like Ozempic and Wegovy revolutionized weight loss, but their high cost keeps them out of reach for most ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...

While Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) still rule the weight-loss drug market with their respective GLP-1 medications, competition could soon be heating up as rival products near ...

FREE TO READ] Critics say fragmented ownership, weak culture and a fixation on financial results have harmed innovation ...

A small problem arises every time a new Bridget Jones film starts production: no-one seems to know who the real Bridget is.

Eli Lilly, BCE, Suncor, Canada Goose, Bombardier, Thomson Reuters and Lightspeed reported earnings this week. Here are the ...

Dr. Maya Green discusses HIV prevention, U=U, and the importance of regular testing, particularly addressing disparities ...

Former followers of the ‘Dark Enlightenment’ say a planned 'neo-reactionary' hollowing out of government is happening in real time ...

New Income Tax law explained: No new taxes, simple read for common man Ram Kapoor sets the record straight on 55 kg weight ...

Some people who use semaglutide (Ozempic, others) have noted sagging skin in the buttocks, calling it “Ozempic butt.” While lifestyle modifications may help prevent this weight loss side ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...